Li Kang Biomedical Co., Ltd. (TPEX:6242)

Li Kang Biomedical Revenue

Li Kang Biomedical had revenue of 118.24M TWD in the quarter ending September 30, 2025, a decrease of -7.12%. This brings the company's revenue in the last twelve months to 581.53M, up 1.42% year-over-year. In the year 2024, Li Kang Biomedical had annual revenue of 565.52M, down -10.15%.

• Revenue (ttm): 581.53M
• Revenue Growth: +1.42%
• P/S Ratio: 2.09
• Revenue / Employee: 4.77M
• Employees: 122
• Market Cap: 1.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	565.52M	-63.86M	-10.15%
Dec 31, 2023	629.38M	-54.87M	-8.02%
Dec 31, 2022	684.25M	297.28M	76.82%
Dec 31, 2021	386.97M	-69.75M	-15.27%
Dec 31, 2020	456.72M	-26.58M	-5.50%